The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor

European Journal of Pharmacology

Volumn 450, Issue 3, 2002, Pages 237-243

  Nagoshi, Yasuko ^a   Kuwasako, Kenji ^a   Ito, Kaoru ^a   Uemura, Tomohiko ^a   Kato, Johji ^a   Kitamura, Kazuo ^a   Eto, Tanenao ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

CGRP (8 37); Adrenomedullin; cAMP; CGRP (Calcitonin gene related peptide); CRL (Calcitonin receptor like) receptor; RAMP (Receptor activity modifying protein)

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE[8-37]; CALCITONIN RECEPTOR LIKE RECEPTOR; CYCLIC AMP; RECEPTOR ACTIVITY MODIFYING PROTEIN; SYNAPSIN I; UNCLASSIFIED DRUG;

ARTICLE; CELL CLONE; CONTROLLED STUDY; DRUG ANTAGONISM; EMBRYO CELL; HUMAN; HUMAN CELL; HUMAN EMBRYO; KIDNEY CELL; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENOMEDULLIN; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; CYCLIC AMP; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, CALCITONIN; RECEPTORS, PEPTIDE; RNA, MESSENGER; TRANSFECTION;

EID: 0037199694     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02184-2     Document Type: Article

References (39)

1. Aiyar N., Rand K., Elshourbagy N.A., Zeng Z., Adamou J.E., Bergsma D.J., Li Y. A cDNA encoding the calcitonin gene-related peptide type 1 receptor. J. Biol. Chem. 271:1996;11325-11329.
2. Aiyar N., Disa J., Pullen M., Nambi P. Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells. Mol. Cell. Biochem. 224:2001;123-133.
3. Ashton D., Hieble P., Gout B., Aiyar N. Vasodilatory effect of adrenomedullin in mouse aorta. Pharmacology. 61:2000;101-105.
4. Brain S.D., Williams T.J., Tippins J.R., Morris H.R., MacIntyre I. Calcitonin gene-related peptide is a potent vasodilator. Nature. 313:1985;54-56.
5. Buhlmann N., Leuthauser K., Muff R., Fischer J.A., Born W. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1. Endocrinology. 140:1999;2883-2890.
6. Chiba T., Yamaguchi A., Yamatani T., Nakamura A., Morishita T., Inui T., Fukase M., Noda T., Fujita T. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol. 256:1989;E331-E335.
7. Christopoulos G., Perry K.J., Morfis M., Tilakaratne N., Gao Y., Fraser N.J., Main M.J., Foord S.M., Sexton P.M. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin gene product. Mol. Pharmacol. 56:1999;235-242.
8. Clementi G., Floriddia M.L., Prato A., Marino A., Drago F. Adrenomedullin and ocular inflammation in the rabbit. Eur. J. Pharmacol. 400:2000;321-326.
9. q/11 during calcium mobilization by calcitonin gene-related peptide. J. Biol. Chem. 273:1998;20168-20174.
10. Eguchi S., Hirata Y., Iwasaki H., Sato K., Watanabe T.X., Inui T., Nakajima K., Sakakibara S., Marumo F. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells. Endocrinology. 135:1994;2454-2458.
11. Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides. 22:2001;1693-1711.
12. Fluhmann B., Muff R., Hunziker W., Fischer J.A., Born W. A human orphan calcitonin receptor-like structure. Biochem. Biophys. Res. Commun. 206:1995;341-347.
13. Fraser N.J., Wise A., Brown J., McLatchie L.M., Main M.J., Foord S.M. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol. Pharmacol. 55:1999;1054-1059.
14. Fujioka H., Okamura T., Toda N. Inhibition by adrenomedullin of amine release from adrenergic nerves in dog mesenteric arteries. Eur. J. Pharmacol. 385:1999;155-161.
15. Hasbak P., Sams A., Schifter S., Longmore J., Edvinsson L. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist. Br. J. Pharmacol. 133:2001;1405-1413.
16. Husmann K., Sexton P.M., Fischer J.A., Born W. Mouse receptor-activity-modifying proteins 1, -2 and -3: amino acid sequence, expression and function. Mol. Cell. Endocrinol. 162:2000;35-43.
17. Kamitani S., Asakawa M., Shimekake Y., Kuwasako K., Nakahara K., Sakata T. The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells. FEBS Lett. 448:1999;111-114.
18. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
19. Kobayashi H., Minami S., Yamamoto R., Masumoto K., Yanagita T., Uezono Y., Tsuchiya K., Mohri M., Kitamura K., Eto T., Wada A. Adrenomedullin receptors in rat cerebral microvessels. Mol. Brain Res. 81:2000;1-6.
20. Kuwasako K., Shimekake Y., Masuda M., Nakahara K., Yoshida T., Kitaura M., Kitamura K., Eto T., Sakata T. Visualization of the calcitonin receptor-like receptor and its receptor activity-modifying proteins during internalization and recycling. J. Biol. Chem. 275:2000;29602-29609.
21. Kuwasako K., Kitamura K., Ito K., Uemura T., Yanagita Y., Kato J., Sakata T., Eto T. The seven amino acids of human RAMP2 (86-92) and RAMP3 (59-65) are critical for agonist binding to human adrenomedullin receptors. J. Biol. Chem. 276:2001;49459-49465.
22. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
23. Mishima K., Kato J., Kuwasako K., Ito K., Imamura T., Kitamura K., Eto T. Effects of endothelin on adrenomedullin secretion and expression of adrenomedullin receptors in rat cardiomyocytes. Biochem. Biophys. Res. Commun. 287:2001;264-269.
24. Muff R., Leuthauser K., Buhlmann N., Foord S.M., Fischer J.A., Born W. Receptor activity modifying proteins regulate the activity of a calcitonin gene-related peptide receptor in rabbit aortic endothelial cells. FEBS Lett. 441:1998;366-368.
25. Nishikimi T., Horio T., Yoshihara F., Nagaya N., Matsuo H., Kangawa K. Effect of adrenomedullin on cAMP and cGMP levels in rat cardiac myocytes and nonmyocytes. Eur. J. Pharmacol. 353:1998;337-344.
26. Nishimura Y., Suzuki A. Relaxant effects of vasodilator peptides on isolated basilar arteries from stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 24:1997;157-161.
27. Nuki C., Kawasaki H., Kitamura K., Takenaga M., Kangawa K., Eto T., Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem. Biophys. Res. Commun. 196:1993;245-251.
28. Okamura T., Ayajiki K., Kangawa K., Toda N. Mechanisms of adrenomedullin-induced relaxation in isolated canine retinal arteries. Investig. Ophthalmol. Vis. Sci. 38:1997;56-61.
29. Oliver K.R., Kane S.A., Salvatore C.A., Mallee J.J., Kinsey A.M., Koblan K.S., Fouladi N.K., Heavens R.P., Wainwright A., Jacobson M., Dickerson I.M., Hill R.G. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur. J. Neurosci. 14:2001;618-628.
30. Osajima A., Uezono Y., Tamura M., Kitamura K., Mutoh Y., Ueta Y., Kangawa K., Kawamura M., Eto T., Yamashita H., Izumi F., Takasugi M., Kuroiwa A. Adrenomedullin-sensitive receptors are preferentially expressed in cultured rat mesangial cells. Eur. J. Pharmacol. 315:1996;319-325.
31. Osajima A., Kato H., Uezono Y., Suda T., Okazaki M., Oishi Y., Tamura M., Tanaka H., Izumi F., Nakashima Y. Adrenomedullin inhibits transmural pressure induced mesangial cell proliferation through activation of protein kinase A. Nephron. 83:1999;352-357.
32. Santiemma V., Rossi F., Guerrini L., Markouizou A., Pasimeni G., Palleschi S., Fabbrini A. Adrenomedullin inhibits the contraction of cultured rat testicular peritubular myoid cells induced by endothelin-1. Biol. Reprod. 64:2001;619-624.
33. 2+ mobilization, in bovine aortic endothelial cells. J. Biol. Chem. 270:1995;4412-4417.
34. Takao M., Tomita M., Tanahashi N., Kobari M., Fukuuchi Y. Transient vasodilatory effects of adrenomedullin on cerebral parenchymal microvessels in cats. Neurosci. Lett. 268:1999;147-150.
35. Tomoda Y., Kikumoto K., Isumi Y., Katafuchi T., Tanaka A., Kangawa K., Dohi K., Minamino N. Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro. Cardiovasc. Res. 49:2001;721-730.
36. Wimalawansa S.J. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit. Rev. Neurobiol. 11:1997;167-239.
37. 2α-induced periodic contraction of rat uterus. Br. J. Pharmacol. 130:2000;1727-1730.
38. Yoshimoto R., Mitsui-Saito M., Ozaki H., Karaki H. Effects of adrenomedullin and calcitonin gene-related peptide on contractions of the rat aorta and porcine coronary artery. Br. J. Pharmacol. 123:1998;1645-1654.
39. Yousufzai S.Y.K., Ali N., Abdel-Latif A.A. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle. Investig. Ophtalmol. Vis. Sci. 40:1999;3245-3253.